With massive upsets in deep red states and stunning wins in Texas, Democrats have redrawn the political map—and decisively ...
InflaRx (NASDAQ:IFRX) outlined plans to advance its oral C5a receptor antagonist izicopan in ANCA-associated vasculitis (AAV) ...